Law ❯ Litigation ❯ Securities Law ❯ Class Action

Investor Rights

Trip.com Investors Face May 11 Deadline to Seek Lead Role in U.S. Securities Case

Plaintiff firms are recruiting shareholders following a report of a Chinese antitrust probe that sent the stock tumbling.

ImmunityBio Securities Fight Intensifies After FDA Rebuke Over Anktiva Claims

Medpace Faces Securities Class Action as Law Firms Rally Investors

Law Firms Urge Vital Farms Investors To Seek Lead Role Before May 26 Deadline

Rosen and Pomerantz Court Trip.com Investors for Lead Role in U.S. Securities Suit

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Law Firms Court PSIX Investors to Lead Securities Suit Over Data‑Center Claims

Lufax Investors Urged to Seek Lead Role in Securities Suit as May 20 Deadline Nears

Navan Securities Suit Seeks Lead Plaintiff as April 24 Deadline Nears

Apollo Investors Face May 1 Deadline to Seek Lead Role in Suit Over Epstein Disclosures

Super Micro Investors Sought to Lead Securities Suits After DOJ Export-Control Indictment

Eos Energy Investors Face May 5 Deadline in Securities Case Over Factory Setbacks

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

Law Firms Press Oddity Tech Investors to Seek Lead Role in Securities Case by May 11

ImmunityBio Faces Investor Suits After FDA Rebuke as Anktiva Sales Jump

Kyndryl Investors Face April 13 Deadline to Seek Lead Role in Securities Case

Trip.com Investors Sought to Lead U.S. Securities Case as May 11 Deadline Nears

Coty Investors Face May 22 Deadline to Seek Lead Role in Securities Class Action

PSIX Investors Urged to Seek Lead Role in Newly Filed Securities Case

Gemini Space Station Investors Face May 18 Deadline in SDNY Securities Class Action